Waning mRNA-1273 vaccine effectiveness against SARS-CoV-2 infection in Qatar
LJ Abu-Raddad, H Chemaitelly… - New England Journal of …, 2022 - Mass Medical Soc
LJ Abu-Raddad, H Chemaitelly, R Bertollini
New England Journal of Medicine, 2022•Mass Medical SocWaning SARS-CoV-2 Immunity in Qatar The protection afforded by the mRNA-1273 vaccine
against SARS-CoV-2 infection in Qatar seemed to wane over several months after
vaccination; however, protection against serious infection, hospitalization, and death
showed no evidence of decline over at least 6 months.
against SARS-CoV-2 infection in Qatar seemed to wane over several months after
vaccination; however, protection against serious infection, hospitalization, and death
showed no evidence of decline over at least 6 months.
Waning SARS-CoV-2 Immunity in Qatar
The protection afforded by the mRNA-1273 vaccine against SARS-CoV-2 infection in Qatar seemed to wane over several months after vaccination; however, protection against serious infection, hospitalization, and death showed no evidence of decline over at least 6 months.
The New England Journal Of Medicine以上显示的是最相近的搜索结果。 查看全部搜索结果